Long-acting implantable corticosteroid matrix for chronic rhinosinusitis: Results of LANTERN Phase 2 randomized controlled study.

Cervin, Anders; Rimmer, Joanne; Wrobel, Agnieszka; Abelak, Yogen; Brayton, Lindsay; Kuang, Yina

Cervin, Anders; Rimmer, Joanne; Wrobel, Agnieszka; Abelak, Yogen; Brayton, Lindsay; Kuang, Yina.

Afiliação

Cervin A; University of Queensland Centre for Clinical Research, Royal Brisbane & Women's Hospital Campus, Herston, QLD, Australia.
Rimmer J; Monash Health and Department of Surgery, Monash University, Melbourne, VIC, Australia.
Wrobel A; Centrum Medyczne, AllMed, Lodz, Poland.
Abelak Y; VistaMed Sp. z o.o., Rzeszów, Poland.
Brayton L; Lyra Therapeutics, Inc, Watertown, MA.
Kuang Y; Lyra Therapeutics, Inc, Watertown, MA.

Int Forum Allergy Rhinol ; 12(2): 147-159, 2022 02.

Article em En | MEDLINE | ID: mdl-34534410

Assuntos

Pólipos Nasais; Rinite; Sinusite; Corticosteroides/uso terapêutico; Adulto; Doença Crônica; Humanos; Pólipos Nasais/tratamento farmacológico; Rinite/tratamento farmacológico; Sinusite/tratamento farmacológico; Resultado do Tratamento

Palavras-chave

chronic sinusitis; local drug delivery; mometasone furoate; nasal polyps; sinus procedure; surgically naive

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sinusite / Rinite / Pólipos Nasais Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google